Skip to search.
 FTSE 100 Up 0.31%

More On BTG.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

BTG plc (BTG.L)

-LSE Ticker: 100159/ISIN: GB0001001592
612.50 Down 7.00(1.13%) 26 Aug 17:14
Prev Close:619.50
Open:619.50
Bid:541.00 x 66000
Ask:N/A x 112600
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:610.00 - 619.50
52wk Range:504.00 - 739.50
Volume:322,400
Avg Vol (3m):696,070
Market Cap:2.35b
P/E (ttm):39.26
EPS (ttm):15.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):530.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback